Click here to see an annotated bibliography of the data in the table.
This is a table of authors, titles, dates and other bibliographic information; it is a list metadata describing the content of your study carrel. Think of it as your library.
id | author | title | date | words | sentences | text |
---|---|---|---|---|---|---|
cord-001546-ndz3oarf | Ayithan, Natarajan | Virus-Like Particles Activate Type I Interferon Pathways to Facilitate Post-Exposure Protection against Ebola Virus Infection | 2015-02-26 | 5128 | 298 | view text |
cord-000547-adfigzc1 | Beniac, Daniel R. | The Organisation of Ebola Virus Reveals a Capacity for Extensive, Modular Polyploidy | 2012-01-11 | 7782 | 392 | view text |
cord-000804-0hlj6r10 | Brauburger, Kristina | Forty-Five Years of Marburg Virus Research | 2012-10-01 | 14922 | 730 | view text |
cord-296399-vvbjulm9 | Brinkmann, Constantin | The glycoprotein of vesicular stomatitis virus promotes release of virus-like particles from tetherin-positive cells | 2017-12-07 | 7009 | 340 | view text |
cord-325423-d212h4bp | Carrion, Ricardo | A small nonhuman primate model for filovirus-induced disease | 2011-11-01 | 4925 | 274 | view text |
cord-002463-qhtj1pef | Dash, Raju | In silico-based vaccine design against Ebola virus glycoprotein | 2017-03-21 | 5830 | 358 | view text |
cord-336986-rmxin1da | De Clercq, Erik | New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections | 2019-08-07 | 2711 | 221 | view text |
cord-004069-nuep8nim | DeWald, Lisa Evans | In Vivo Activity of Amodiaquine against Ebola Virus Infection | 2019-12-27 | 5707 | 288 | view text |
cord-011129-btaxvmsr | Di Paola, Nicholas | Viral genomics in Ebola virus research | 2020-05-04 | 9440 | 433 | view text |
cord-352492-6ihyiwgb | Eickmann, Markus | Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively | 2018-05-06 | 3005 | 164 | view text |
cord-001513-p7v5p036 | Ekins, Sean | A common feature pharmacophore for FDA-approved drugs inhibiting the Ebola virus | 2014-12-12 | 4756 | 250 | view text |
cord-288029-6l91knu3 | Elfiky, Abdo A. | Ebola virus glycoprotein GP1—host cell-surface HSPA5 binding site prediction | 2020-04-14 | 3082 | 206 | view text |
cord-284845-on97zu6w | Falcinelli, Shane D. | Integration of Global Analyses of Host Molecular Responses with Clinical Data To Evaluate Pathogenesis and Advance Therapies for Emerging and Re-emerging Viral Infections | 2016-07-29 | 8473 | 421 | view text |
cord-289413-mbrw85og | Flego, Michela | Intracellular human antibody fragments recognizing the VP35 protein of Zaire Ebola filovirus inhibit the protein activity | 2019-09-05 | 5528 | 243 | view text |
cord-354068-4qlk6y7h | Friedrich, Brian M. | Potential Vaccines and Post-Exposure Treatments for Filovirus Infections | 2012-09-21 | 10605 | 540 | view text |
cord-004126-u6ts87ur | Furuyama, Wakako | A single dose of a vesicular stomatitis virus-based influenza vaccine confers rapid protection against H5 viruses from different clades | 2020-01-10 | 6034 | 333 | view text |
cord-335093-tc1qo2k0 | Gehring, Gerrit | The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry | 2014-08-01 | 5187 | 267 | view text |
cord-344316-mwnnmwnw | Herst, C.V. | An Effective CTL Peptide Vaccine for Ebola Zaire Based on Survivors’ CD8+ Targeting of a Particular Nucleocapsid Protein Epitope with Potential Implications for COVID-19 Vaccine Design | 2020-04-28 | 3495 | 194 | view text |
cord-001764-njzyu4mv | Hofmann-Winkler, Heike | Comparative Analysis of Host Cell Entry of Ebola Virus From Sierra Leone, 2014, and Zaire, 1976 | 2015-10-01 | 4175 | 202 | view text |
cord-342052-v4y1xc90 | Horigan, Verity | Application of a quantitative entry assessment model to compare the relative risk of incursion of zoonotic bat-borne viruses into European Union Member States | 2017-10-02 | 12804 | 611 | view text |
cord-334560-1j9zmuub | Hunt, Catherine L. | Filovirus Entry: A Novelty in the Viral Fusion World | 2012-02-07 | 6445 | 301 | view text |
cord-327641-hqnem2zs | Ji, Ying-Jie | Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone | 2016-11-03 | 5871 | 300 | view text |
cord-256187-ofp7tupv | Kühl, A. | How Ebola Virus Counters the Interferon System | 2012-09-07 | 8609 | 439 | view text |
cord-001542-f089bs8r | Lai, Kang Yiu | Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus | 2014-11-28 | 11274 | 604 | view text |
cord-003917-bswndfvk | Lalle, Eleonora | Pulmonary Involvement during the Ebola Virus Disease | 2019-08-24 | 5545 | 245 | view text |
cord-002500-9p2n8tjx | Lambe, Teresa | A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines? | 2017-05-26 | 7327 | 288 | view text |
cord-350565-mejd7blb | Lewnard, Joseph A | Emerging Challenges and Opportunities in Infectious Disease Epidemiology | 2019-03-16 | 6614 | 289 | view text |
cord-276437-5gkdotvt | Liu, William J. | Intra-host Ebola viral adaption during human infection | 2019-02-20 | 5115 | 251 | view text |
cord-274377-57zy6unz | Long, Jason | Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry | 2015-02-10 | 3938 | 205 | view text |
cord-293481-bmfj50fb | Malin, Jakob J. | Remdesivir against COVID-19 and Other Viral Diseases | 2020-10-14 | 9097 | 428 | view text |
cord-294342-7ycgd0h7 | Markosyan, Ruben M. | Induction of Cell-Cell Fusion by Ebola Virus Glycoprotein: Low pH Is Not a Trigger | 2016-01-05 | 11740 | 548 | view text |
cord-300133-yc2wxgid | Martínez, Miguel J. | Ebola Virus Infection: Overview and Update on Prevention and Treatment | 2015-09-12 | 4302 | 243 | view text |
cord-288734-xinkqs6u | Muñoz-Fontela, César | Ebola Virus Disease in Humans: Pathophysiology and Immunity | 2017-03-30 | 9957 | 451 | view text |
cord-279152-yh7x7w2q | Ndungo, Esther | A Single Residue in Ebola Virus Receptor NPC1 Influences Cellular Host Range in Reptiles | 2016-03-30 | 5230 | 243 | view text |
cord-002185-oz7hras7 | Nelson, Elizabeth A. | Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic Implications | 2016-08-02 | 5047 | 249 | view text |
cord-355737-o0y4rn0z | Ng, Melinda | Filovirus receptor NPC1 contributes to species-specific patterns of ebolavirus susceptibility in bats | 2015-12-23 | 8935 | 422 | view text |
cord-350083-kldu8q8x | Oany, Arafat Rahman | Highly conserved regions in Ebola virus RNA dependent RNA polymerase may be act as a universal novel peptide vaccine target: a computational approach | 2015-08-08 | 5019 | 315 | view text |
cord-267941-nrluar4e | Park, Eun-Mee | Production of Ebola virus-like particles in Drosophila melanogaster Schneider 2 cells | 2018-08-23 | 2162 | 127 | view text |
cord-003859-k8wfyj9b | Paweska, Janusz T. | Evaluation of Diagnostic Performance of Three Indirect Enzyme-Linked Immunosorbent Assays for the Detection of IgG Antibodies to Ebola Virus in Human Sera | 2019-07-24 | 6407 | 308 | view text |
cord-004335-bw3tziup | Perez-Zsolt, Daniel | When Dendritic Cells Go Viral: The Role of Siglec-1 in Host Defense and Dissemination of Enveloped Viruses | 2019-12-19 | 7360 | 388 | view text |
cord-002935-jq1xumrh | Postnikova, Elena | Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs | 2018-03-22 | 6226 | 315 | view text |
cord-303647-c4umbcvn | Reed, Patricia E. | A New Approach for Monitoring Ebolavirus in Wild Great Apes | 2014-09-18 | 5636 | 256 | view text |
cord-305653-f9vqn96o | Schmidt, Rebecca | Generation of therapeutic antisera for emerging viral infections | 2018-10-05 | 7902 | 377 | view text |
cord-102206-mb0qcd0b | Seymour, Elif | Configurable Digital Virus Counter on Robust Universal DNA Chips | 2020-10-22 | 5898 | 284 | view text |
cord-003779-5yhoiv76 | Singleton, Courtney D. | Identification of Ebola Virus Inhibitors Targeting GP2 Using Principles of Molecular Mimicry | 2019-07-17 | 8976 | 434 | view text |
cord-318587-ewvnkdr2 | Steeds, Kimberley | Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies | 2020-08-31 | 4973 | 244 | view text |
cord-337998-08tknscm | Sztuba-Solinska, Joanna | A small stem-loop structure of the Ebola virus trailer is essential for replication and interacts with heat-shock protein A8 | 2016-11-16 | 8269 | 434 | view text |
cord-017811-w38mbvdw | Volchkov, Viktor | Proteolytic Processing of Filovirus Glycoproteins | 2018-02-16 | 3525 | 186 | view text |
cord-272576-ez731lif | Wada, Yoshiko | Directional and reoccurring sequence change in zoonotic RNA virus genomes visualized by time-series word count | 2016-11-03 | 5641 | 273 | view text |
cord-346267-l08ld2cy | Wertheim, Joel O. | Purifying Selection Can Obscure the Ancient Age of Viral Lineages | 2011-06-24 | 6414 | 327 | view text |
cord-284791-bgodmbru | Whitworth, Carrie | Persistence of Bacteriophage Phi 6 on Porous and Nonporous Surfaces and the Potential for Its Use as an Ebola Virus or Coronavirus Surrogate | 2020-08-18 | 5152 | 250 | view text |
cord-296517-414grqif | Wong, Gary | MERS, SARS, and Ebola: The Role of Super-Spreaders in Infectious Disease | 2015-10-14 | 2880 | 129 | view text |
cord-330647-w1bpeqzg | Wong, Samson Sai-Yin | Ebola virus disease in nonendemic countries | 2015-05-31 | 8637 | 507 | view text |
cord-322748-a5131tv9 | Yates, Mary K. | Flex-nucleoside analogues – Novel therapeutics against filoviruses | 2017-06-15 | 1492 | 78 | view text |
cord-297082-2rhoffx2 | Yu, Changqing | MARCH8 Inhibits Ebola Virus Glycoprotein, Human Immunodeficiency Virus Type 1 Envelope Glycoprotein, and Avian Influenza Virus H5N1 Hemagglutinin Maturation | 2020-09-15 | 6423 | 410 | view text |
cord-002676-zwkl1ywk | Yu, Dong-Shan | The lifecycle of the Ebola virus in host cells | 2017-06-15 | 5322 | 287 | view text |
cord-102763-tc1z0nm9 | Zhang, Yuan | IgY antibodies against Ebola virus possess post-exposure protection and excellent thermostability | 2020-05-21 | 1764 | 104 | view text |
cord-002013-rb9xdzro | Zheng, Xuexing | Treatment with hyperimmune equine immunoglobulin or immunoglobulin fragments completely protects rodents from Ebola virus infection | 2016-04-12 | 6027 | 286 | view text |